Tabassom Mohajer Shojai
Visiting researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Precision Medicine; Research group Marika Nestor
- E-mail:
- tabassom.mohajer@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Publications
Recent publications
-
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 768-778, 2024
- DOI for p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
- Download full text (pdf) of p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
-
Enhancing Cancer Treatment through Combination Therapies
2024
-
Part of Cancers, 2023
- DOI for Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Download full text (pdf) of Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
-
Photoactive immunoconjugates for targeted photodynamic therapy of cancer
Part of Journal of Photochemistry and Photobiology. B, 2023
-
Part of Frontiers in Oncology, 2022
- DOI for In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
- Download full text (pdf) of In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
All publications
Articles in journal
-
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 768-778, 2024
- DOI for p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
- Download full text (pdf) of p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
-
Part of Cancers, 2023
- DOI for Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
- Download full text (pdf) of Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts
-
Photoactive immunoconjugates for targeted photodynamic therapy of cancer
Part of Journal of Photochemistry and Photobiology. B, 2023
-
Part of Frontiers in Oncology, 2022
- DOI for In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
- Download full text (pdf) of In Vitro Characterization of Lu-177-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
-
Part of Frontiers in Oncology, 2020
- DOI for Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
- Download full text (pdf) of Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib